首页> 外文期刊>Cancer immunity >Prognostic Impact of Human Leukocyte Antigen Class I Expression and Association of Platinum Resistance with Immunologic Profiles in Epithelial Ovarian Cancer
【24h】

Prognostic Impact of Human Leukocyte Antigen Class I Expression and Association of Platinum Resistance with Immunologic Profiles in Epithelial Ovarian Cancer

机译:人白细胞抗原I类表达的预后影响以及上皮性卵巢癌中铂耐药性与免疫学特征的关系

获取原文
           

摘要

Epithelial ovarian cancer (EOC) is one of the most deadly carcinomas in females. Immune systems can recognize EOCs; however, a defect of human leukocyte antigen (HLA) class I expression is known to be a major mechanism for escape from immune systems, resulting in poor prognosis. The purpose of this study is to identify novel correlations between immunologic responses and other clinical factors. We investigated the expression of immunologic components in 122 cases of EOCs for which surgical operations were performed between 2001 and 2011. We immunohistochemically stained EOC specimens using an anti-pan HLA class I monoclonal antibody (EMR8-5) and anti-CD3, -CD4, and -CD8 antibodies, and we analyzed correlations between immunologic parameters and clinical factors. In multivariate analysis that used the Cox proportional hazards model, independent prognostic factors for overall survival in advanced EOCs included low expression level of HLA class I [risk ratio (RR), 1.97; 95% confidence interval (CI), 1.01a??3.83; P = 0.046] and loss of intraepithelial cytotoxic T lymphocyte (CTL) infiltration (RR, 2.11; 95% CI, 1.06a??4.20; P = 0.033). Interestingly, almost all platinum-resistant cases showed a significantly low rate of intraepithelial CTL infiltration in the ?? 2 test (positive vs. negative: 9.0% vs. 97.7%; P 0.001). Results from a logistic regression model revealed that low CTL infiltration rate was an independent factor of platinum resistance in multivariate analysis (OR, 3.77; 95% CI, 1.08a??13.12; P = 0.037). Platinum-resistant EOCs show poor immunologic responses. The immune escape system of EOCs may be one of the mechanisms of platinum resistance. Cancer Immunol Res; 2(12); 1220a??9. ??2014 AACR .
机译:上皮性卵巢癌(EOC)是女性中最致命的癌症之一。免疫系统可以识别EOC;然而,已知人类白细胞抗原(HLA)I类表达缺陷是逃避免疫系统的主要机制,导致预后不良。这项研究的目的是确定免疫反应和其他临床因素之间的新型关联。我们调查了2001年至2011年进行手术的122例EOC中免疫成分的表达。我们使用抗泛型HLA I类单克隆抗体(EMR8-5)和抗CD3,-CD4对组织进行了免疫组织化学染色和-CD8抗体,我们分析了免疫学参数与临床因素之间的相关性。在使用Cox比例风险模型的多变量分析中,晚期EOC总体生存的独立预后因素包括低表达水平的HLA I类[风险比(RR),1.97; 95%置信区间(CI),1.01a≤3.83; P = 0.046]和上皮内细胞毒性T淋巴细胞(CTL)浸润的丧失(RR,2.11; 95%CI,1.06a≤4.20; P = 0.033)。有趣的是,几乎所有对铂有抗药性的病例在??中均表现出明显较低的上皮内CTL浸润率。 2个测试(阳性vs.阴性:9.0%vs. 97.7%; P <0.001)。 Logistic回归模型的结果表明,低CTL渗透率是多变量分析中铂耐药性的独立因素(OR为3.77; 95%CI为1.08a?13.12; P = 0.037)。耐铂类的EOC显示出较差的免疫反应。 EOC的免疫逃逸系统可能是铂耐药的机制之一。癌症免疫研究; 2(12); 1220a ?? 9。 ?? 2014 AACR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号